healthcare
HMC cautions public about foot ulcer risks
May 23, 2022
Building on the previous success of education and awareness activities, Hamad Medical Corporation (HMC) recently joined the American Diabetic Awareness......
Continue Reading >
Sony's profit surges on healthy film, game, music growth
May 11, 2022
Sony's fiscal fourth quarter surged 67% to 111.1 billion yen ($852.7 million) from the previous year, as the Japanese entertainment and electronics......
Continue Reading >
Amazon workers in NYC reject union in a reversal of fortune
May 4, 2022
Amazon workers at a warehouse on New York City’s Staten Island overwhelmingly rejected a union bid on Monday, dealing a blow to organizers......
Continue Reading >
Lebanon’s crisis exposes kids to deadly viruses
April 21, 2022
BEIRUT: Child vaccination rates in Lebanon have dropped by more than 30 percent, compounding a health crisis marked by drug shortages and an exodus......
Continue Reading >
Rhizen Pharmaceuticals AG Presents Data on Its Differentiated PARP and DHODH Inhibitor Programs at AACR 2022
April 14, 2022
Rhizen Pharma announces presentations at AACR showcasing its differentiated clinical stage PARP and DHODH programs Preclinical data on Rhizen’s......
Continue Reading >
STALICLA Completes Successful Phase 1b Trials for the First Precision Medicine in Autism Spectrum Disorder
April 13, 2022
STALICLA, a Swiss clinical stage biotech company leading omics-based drug development for patients with neurodevelopmental disorders (NDDs), announced......
Continue Reading >
Lancer Dermatology Announces Partnership with Forefront Dermatology
April 4, 2022
Premier Beverly Hills-based dermatology practice, Lancer Dermatology, announced today that it has partnered with Forefront Dermatology, the largest......
Continue Reading >
The Health Bank and Cedars-Sinai Collaborate to Strengthen Patient Care Services in the Region
March 31, 2022
The Health Bank (THB) Global and Cedars-Sinai are proud to announce a collaboration to implement global standards of excellence in areas of patient-centered......
Continue Reading >
Merck Shares Advances in MS Portfolio with Key Efficacy and Safety Data at AAN 2022
March 31, 2022
New Phase II data show evobrutinib sustained low annualized relapse rates (ARRs) and had no new safety signals at 2.5 years – the longest......
Continue Reading >
pH-optimized skincare and why it matters
March 29, 2022
While most of us focus on exploring different kinds of skincare routines that work best for our skin types, it is imperative to know that a healthy......
Continue Reading >